University of Texas Southwestern Medical Center - Accepting Juvenile Patients, Dallas
Houston Methodist Hospital - Accepting Adult Patients, Houston
University of Texas MD Anderson Cancer Center - Accepting Adult Patients, Houston

ReclutandoFase 2/3

Edades de 6 a 75 · Todos los sexos · Actualizado el 17 sept 2026 · NCT06154252

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

University of Texas - Houston, Houston

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07103746

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Baylor College of Medicine, Houston

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT06948318

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

GSK Investigational Site, Houston
GSK Investigational Site, Temple

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT06572384

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

University of Texas MD Anderson Cancer Center, Houston

ReclutandoFase 1/2

Edades de 18 a 65 · Todos los sexos · Actualizado el 26 ago 2026 · NCT06121297

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

Dallas Renal Group, Dallas
Dallas Renal Group, Dallas
Nephro Asso North Illinois Indiana, Houston

ReclutandoFase 3

Edades de 18 a 100 · Todos los sexos · Actualizado el 17 ago 2026 · NCT06858319

Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study

University of Texas at Austin, Austin

Reclutando

Edades de 18 a 80 · Todos los sexos · Actualizado el 17 ago 2026 · NCT07759115

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

Baylor College of Medicine Neurology Department, Houston
Houston Methodist Hospital, Houston
University of Texas MD Anderson Cancer Center, Houston

ReclutandoFase 1/2

Edades de 18 a 70 · Todos los sexos · Actualizado el 13 ago 2026 · NCT06359041

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

MD Anderson Cancer Center, Houston

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 6 ago 2026 · NCT06817889

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

UT Southwestern Medical Center, Dallas
Cook Children's Medical Center, Fort Worth
Texas Children's Hospital/ Baylor College of Medicine, Houston
y 1 más

ReclutandoFase 3

Edades de 12 en adelante · Todos los sexos · Actualizado el 6 ago 2026 · NCT06056297

Study of BHV-1300 in Graves' Disease

Site-109, Dallas
Site-106, Houston
Site-101, Houston
y 1 más

ReclutandoFase 1

Edades de 18 a 65 · Todos los sexos · Actualizado el 31 jul 2026 · NCT06980649

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Site Number - 1003, Dallas
Site Number - 1047, Denton
Site Number - 1057, Houston
y 1 más

ReclutandoFase 3

Edades de 18 a 80 · Todos los sexos · Actualizado el 30 jul 2026 · NCT07039916

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

Houston Methodist Hospital, Houston

ReclutandoFase 2/3

Edades de 18 a 75 · Todos los sexos · Actualizado el 29 jul 2026 · NCT06193889

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Medical City Dallas, Dallas
Children's Medical Center Dallas, Dallas
Zachary & Elizabeth Fisher Bone Marrow Transplant Program (Brooke Army Medical Center), Fort Sam Houston
y 5 más

ReclutandoEstudio observacional

Todas las edades · Todos los sexos · Actualizado el 6 jul 2026 · NCT01351545

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

UT Southwestern Medical Center, Dept. of Dermatology, Dallas
MD Anderson Texas Medical Center, Houston

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 may 2026 · NCT04422912

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M D Anderson Cancer Center, Houston

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 20 may 2026 · NCT04751396

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

MD Anderson Cancer Center, Houston
The University of Texas Health Science Center at Houston, Houston

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 15 abr 2026 · NCT06434363

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

UT Southwestern Medical Center, Dallas
Houston Methodist Hospital, Houston

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 feb 2026 · NCT06626919

De ClinicalTrials.gov, datos obtenidos el 29 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.